Cardiovascular

Endovascular thrombectomy versus medical management in patients with dementia and acute ischaemic stroke.

TL;DR

Treatment response to EVT among LVO stroke patients with dementia was heterogeneous, and EVT was beneficial for patients <75 years old and those with vascular dementia.

Key Findings

Overall home discharge rates were similar between EVT and BMM groups in dementia patients with LVO stroke.

  • Among 37,298 total patients identified, 6,618 EVT and 13,092 BMM patients remained after propensity score matching.
  • Home discharge rates were 27.1% for EVT versus 26.4% for BMM (P = .51).
  • Data were drawn from the US Nationwide Readmissions Database from 2016 to 2022.
  • Propensity score matching was used to balance comparison groups.

EVT was associated with longer length-of-stay and increased intracranial haemorrhage compared to BMM.

  • Median length-of-stay was 7 days for EVT versus 6 days for BMM (P < .001).
  • Intracranial haemorrhage occurred in 23.9% of EVT patients versus 11.1% of BMM patients (P < .001).
  • These differences were statistically significant after propensity score matching.

In-hospital mortality did not significantly differ between EVT and BMM groups.

  • Mortality rates were 15.0% for EVT versus 14.9% for BMM (P = .87).
  • No significant difference in mortality was observed despite the increased rate of intracranial haemorrhage in the EVT group.

Patient age significantly moderated EVT effectiveness, with EVT associated with higher home discharge rates in patients younger than 75 years.

  • Age significantly moderated EVT effectiveness (interaction P < .001).
  • Among patients <75 years old, home discharge rates were 36.7% for EVT versus 26.8% for BMM (P < .001).
  • This subgroup analysis was pre-specified as part of interaction and subgroup analyses assessing treatment effect heterogeneity.

EVT appeared more effective for patients with vascular dementia compared to those with Alzheimer's disease.

  • Dementia type significantly moderated EVT effectiveness (interaction P = .014).
  • Among vascular dementia patients, EVT was associated with significantly higher rates of home discharge (32.7% vs 25.2%, P = .007).
  • The interaction effect suggests differential benefit by dementia subtype, with Alzheimer's disease patients showing less benefit from EVT.

Pre-existing dementia is a known negative predictor for good EVT outcomes, but comparative efficacy and safety data of EVT versus BMM for LVO patients with dementia were previously limited.

  • The study was motivated by limited comparative efficacy and safety data of EVT versus BMM specifically for large vessel occlusion patients with dementia.
  • This retrospective study used a large national database (US Nationwide Readmissions Database, 2016–2022) to address this gap.
  • Primary outcome was discharge to home; secondary outcomes included in-hospital mortality, length-of-stay, and complications.

What This Means

This research suggests that for stroke patients who also have dementia, the benefit of endovascular thrombectomy (EVT) — a procedure that physically removes the blood clot causing the stroke — depends heavily on the patient's age and type of dementia. Using a large U.S. hospital database covering 2016 to 2022, researchers compared over 19,000 dementia patients who had a large vessel occlusion stroke and received either EVT or medication-only treatment. Overall, the two groups had similar rates of being discharged home (about 27%), but EVT patients had more brain bleeding and longer hospital stays, with no difference in death rates. However, when researchers looked at specific subgroups, important differences emerged. Dementia patients younger than 75 who received EVT were significantly more likely to be discharged home (36.7% vs. 26.8%) compared to those who only received medication. Similarly, patients with vascular dementia — a type caused by reduced blood flow to the brain — benefited more from EVT than those with Alzheimer's disease, with higher home discharge rates (32.7% vs. 25.2%). This research suggests that decisions about whether to perform EVT in stroke patients with dementia should not be one-size-fits-all. Younger patients and those with vascular dementia appear to benefit from the procedure, while older patients and those with Alzheimer's disease may not see the same advantage. These findings could help clinicians and families have more informed conversations about treatment options when a dementia patient experiences a severe stroke.

Have a question about this study?

Citation

Chen H, Mcintyre M, Aktay S, Yen M, Gunawardane S, Lakhani D, et al.. (2026). Endovascular thrombectomy versus medical management in patients with dementia and acute ischaemic stroke.. Age and ageing. https://doi.org/10.1093/ageing/afag241